Shield Therapeutics Market Cap

Shield Therapeutics has a market cap or net worth of 71.58 million as of May 7, 2026. Its market cap has increased by 192.42% in one year.

Market Cap

71.58M

Enterprise Value

85.34M

Revenue

36.93M

Ranking

n/a

PE Ratio

n/a

Stock Price

6.75

Market Cap Chart

Since February 26, 2016, Shield Therapeutics's market cap has decreased from 169.77M to 71.58M, a decrease of -57.84%. That is a compound annual growth rate of -8.12%.

Market Cap History

Date	Market Cap	% Change
May 6, 2026	71.58M	-31.56%
Dec 31, 2025	104.59M	395.31%
Dec 31, 2024	21.12M	-59.70%
Dec 29, 2023	52.40M	186.53%
Dec 30, 2022	18.29M	-80.96%
Dec 31, 2021	96.06M	28.62%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Haleon	29.66B
Hikma Pharmaceuticals	3.03B
HUTCHMED (China)	1.68B
Allergy Therapeutics	649.08M
Venture Life Group	68.83M
ECO Animal Health Group	63.36M
Provexis	23.46M
Chill Brands Group	2.09M

Market Cap Rankings